Dr. Sandeep Kumar

Dr. Sandeep Kumar is the Founder of PearlOmics and a PhD scholar in Cardiology with CSIR-NET qualification and nearly a decade of experience in academic research. His expertise spans computational biology, next-generation sequencing (NGS), CRISPR technologies, systems biology, artificial intelligence in drug discovery, and bioinformatics. His research contributions include cardiovascular genetics, genome evolution, molecular mimicry, antimicrobial resistance, sustainable agriculture, and systems biology, with publications in peer-reviewed journals, books, and edited volumes. As an educator and mentor, Dr. Kumar is committed to bridging biology and computational sciences, empowering aspiring researchers through interdisciplinary training and translational research. His work integrates advanced biological data analysis with innovative technologies to address challenges in precision medicine, biotechnology, and life sciences.

Large-scale whole-genome sequencing reveals the landscape and health implications of de novo mutations

August 10, 2026 by Dr. Sandeep Kumar

Intracytoplasmic Sperm Injection (ICSI) under an inverted light microscope

Large-scale whole-genome sequencing reveals the landscape and health implications of de novo mutations De novo mutations (DNMs), spontaneous genetic alterations arising in the germline or early embryonic development that are absent in parental genomes, are a critical driver of congenital diseases and developmental disorders. With global trends shifting toward delayed …

Beyond algorithms: How patient journeys are transforming AI driven drug discovery

August 5, 2026 by Dr. Sandeep Kumar

Artificial intelligence, or AI, has completely changed the game for drug discovery, speeding up everything from finding drug targets to mapping protein structures. It is like giving scientists a powerful telescope that can see possibilities hidden from the human eye. But there is a catch, AI is only as smart …